Channing R Beals

Title: Channing R Beals: Innovator in Vaccination Methods

Introduction

Channing R Beals is a notable inventor based in Solana Beach, CA (US). He has made significant contributions to the field of immunization, particularly concerning the varicella zoster virus (VZV). His innovative approach to vaccination has the potential to enhance the effectiveness of immunization strategies.

Latest Patents

Channing R Beals holds a patent for "Methods of immunization with varicella zoster virus antigen." This invention relates to a method of vaccinating a patient against VZV by delivering an effective amount of a live attenuated VZV vaccine to the epidermis or dermis of a patient's skin at a depth of between about 100 and about 700 microns from the surface of the skin. This method is particularly useful for preventing herpes zoster or reducing the severity or duration of the condition. The invention also addresses the prevention of VZV infection in individuals who have not previously been infected.

Career Highlights

Channing R Beals is associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His work focuses on advancing vaccination techniques and improving public health outcomes. With a patent count of 1 patent, he has demonstrated his commitment to innovation in the medical field.

Collaborations

Channing has collaborated with notable colleagues, including Brian K Meyer and Robert K Evans. These partnerships have likely contributed to the development and refinement of his innovative vaccination methods.

Conclusion

Channing R Beals is a distinguished inventor whose work in vaccination methods has the potential to significantly impact public health. His innovative approach to immunization against varicella zoster virus showcases the importance of research and development in the medical field.